+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cell Lysis/Cell Fractionation - Global Market Trajectory & Analytics

  • ID: 5029787
  • Report
  • April 2021
  • Region: Global
  • 174 Pages
  • Global Industry Analysts, Inc
Global Cell Lysis/Cell Fractionation Market to Reach $6 Billion by 2027

Amid the COVID-19 crisis, the global market for Cell Lysis/Cell Fractionation estimated at US$3.3 Billion in the year 2020, is projected to reach a revised size of US$6 Billion by 2027, growing at a CAGR of 9% over the period 2020-2027. Consumables, one of the segments analyzed in the report, is projected to record 10.4% CAGR and reach US$3.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 6.8% CAGR for the next 7-year period.



The U.S. Market is Estimated at $976.1 Million, While China is Forecast to Grow at 8.3% CAGR

The Cell Lysis/Cell Fractionation market in the U.S. is estimated at US$976.1 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$1 Billion by the year 2027 trailing a CAGR of 8.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.3% and 7.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.2% CAGR.

Select Competitors (Total 44 Featured):
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Cell Signaling Technology, Inc.
  • Merck KgaA
  • Miltenyi Biotec GmbH
  • Qiagen NV
  • Qsonica L.L.C.
  • Roche Diagnostics
  • Thermo Fisher Scientific, Inc.
Frequently Asked Questions about the Global Market for Cell Lysis/Cell Fractionation

What is the estimated value of the Global Market for Cell Lysis/Cell Fractionation?

The Global Market for Cell Lysis/Cell Fractionation was estimated to be valued at $3.3 Billion in 2020.

What is the growth rate of the Global Market for Cell Lysis/Cell Fractionation?

The growth rate of the Global Market for Cell Lysis/Cell Fractionation is 8.9%, with an estimated value of $6.0 Billion by 2027.

What is the forecasted size of the Global Market for Cell Lysis/Cell Fractionation?

The Global Market for Cell Lysis/Cell Fractionation is estimated to be worth $6.0 Billion by 2027.
Note: Product cover images may vary from those shown

I. METHODOLOGY
II. EXECUTIVE SUMMARY
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Table 1: World Current & Future Analysis for Cell Lysis/Cell Fractionation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 2: World 7-Year Perspective for Cell Lysis/Cell Fractionation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
  • Table 3: World Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 4: World 7-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 5: World Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 6: World 7-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 7: World Current & Future Analysis for Mammalian Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 8: World 7-Year Perspective for Mammalian Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 9: World Current & Future Analysis for Microbial Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 10: World 7-Year Perspective for Microbial Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 11: World Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 12: World 7-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 13: World Current & Future Analysis for Research Laboratories & Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 14: World 7-Year Perspective for Research Laboratories & Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 15: World Current & Future Analysis for Biopharmaceutical & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 16: World 7-Year Perspective for Biopharmaceutical & Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 17: World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 18: World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

III. MARKET ANALYSIS
  • Table 19: USA Current & Future Analysis for Cell Lysis/Cell Fractionation by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 20: USA 7-Year Perspective for Cell Lysis/Cell Fractionation by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2020 & 2027
  • Table 21: USA Current & Future Analysis for Cell Lysis/Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 22: USA 7-Year Perspective for Cell Lysis/Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2020 & 2027
  • Table 23: USA Current & Future Analysis for Cell Lysis/Cell Fractionation by End-Use - Research Laboratories & Institutes, Biopharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 24: USA 7-Year Perspective for Cell Lysis/Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biopharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2020 & 2027
  • Table 25: Canada Current & Future Analysis for Cell Lysis/Cell Fractionation by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 26: Canada 7-Year Perspective for Cell Lysis/Cell Fractionation by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2020 & 2027
  • Table 27: Canada Current & Future Analysis for Cell Lysis/Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 28: Canada 7-Year Perspective for Cell Lysis/Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2020 & 2027
  • Table 29: Canada Current & Future Analysis for Cell Lysis/Cell Fractionation by End-Use - Research Laboratories & Institutes, Biopharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 30: Canada 7-Year Perspective for Cell Lysis/Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biopharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2020 & 2027
  • Table 31: Japan Current & Future Analysis for Cell Lysis/Cell Fractionation by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 32: Japan 7-Year Perspective for Cell Lysis/Cell Fractionation by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2020 & 2027
  • Table 33: Japan Current & Future Analysis for Cell Lysis/Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 34: Japan 7-Year Perspective for Cell Lysis/Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2020 & 2027
  • Table 35: Japan Current & Future Analysis for Cell Lysis/Cell Fractionation by End-Use - Research Laboratories & Institutes, Biopharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 36: Japan 7-Year Perspective for Cell Lysis/Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biopharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2020 & 2027
  • Table 37: China Current & Future Analysis for Cell Lysis/Cell Fractionation by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 38: China 7-Year Perspective for Cell Lysis/Cell Fractionation by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2020 & 2027
  • Table 39: China Current & Future Analysis for Cell Lysis/Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 40: China 7-Year Perspective for Cell Lysis/Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2020 & 2027
  • Table 41: China Current & Future Analysis for Cell Lysis/Cell Fractionation by End-Use - Research Laboratories & Institutes, Biopharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 42: China 7-Year Perspective for Cell Lysis/Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biopharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2020 & 2027
  • Table 43: Europe Current & Future Analysis for Cell Lysis/Cell Fractionation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 44: Europe 7-Year Perspective for Cell Lysis/Cell Fractionation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
  • Table 45: Europe Current & Future Analysis for Cell Lysis/Cell Fractionation by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 46: Europe 7-Year Perspective for Cell Lysis/Cell Fractionation by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2020 & 2027
  • Table 47: Europe Current & Future Analysis for Cell Lysis/Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 48: Europe 7-Year Perspective for Cell Lysis/Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2020 & 2027
  • Table 49: Europe Current & Future Analysis for Cell Lysis/Cell Fractionation by End-Use - Research Laboratories & Institutes, Biopharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 50: Europe 7-Year Perspective for Cell Lysis/Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biopharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2020 & 2027
  • Table 51: France Current & Future Analysis for Cell Lysis/Cell Fractionation by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 52: France 7-Year Perspective for Cell Lysis/Cell Fractionation by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2020 & 2027
  • Table 53: France Current & Future Analysis for Cell Lysis/Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 54: France 7-Year Perspective for Cell Lysis/Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2020 & 2027
  • Table 55: France Current & Future Analysis for Cell Lysis/Cell Fractionation by End-Use - Research Laboratories & Institutes, Biopharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 56: France 7-Year Perspective for Cell Lysis/Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biopharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2020 & 2027
  • Table 57: Germany Current & Future Analysis for Cell Lysis/Cell Fractionation by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 58: Germany 7-Year Perspective for Cell Lysis/Cell Fractionation by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2020 & 2027
  • Table 59: Germany Current & Future Analysis for Cell Lysis/Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 60: Germany 7-Year Perspective for Cell Lysis/Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2020 & 2027
  • Table 61: Germany Current & Future Analysis for Cell Lysis/Cell Fractionation by End-Use - Research Laboratories & Institutes, Biopharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 62: Germany 7-Year Perspective for Cell Lysis/Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biopharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2020 & 2027
  • Table 63: Italy Current & Future Analysis for Cell Lysis/Cell Fractionation by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 64: Italy 7-Year Perspective for Cell Lysis/Cell Fractionation by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2020 & 2027
  • Table 65: Italy Current & Future Analysis for Cell Lysis/Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 66: Italy 7-Year Perspective for Cell Lysis/Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2020 & 2027
  • Table 67: Italy Current & Future Analysis for Cell Lysis/Cell Fractionation by End-Use - Research Laboratories & Institutes, Biopharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 68: Italy 7-Year Perspective for Cell Lysis/Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biopharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2020 & 2027
  • Table 69: UK Current & Future Analysis for Cell Lysis/Cell Fractionation by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 70: UK 7-Year Perspective for Cell Lysis/Cell Fractionation by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2020 & 2027
  • Table 71: UK Current & Future Analysis for Cell Lysis/Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 72: UK 7-Year Perspective for Cell Lysis/Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2020 & 2027
  • Table 73: UK Current & Future Analysis for Cell Lysis/Cell Fractionation by End-Use - Research Laboratories & Institutes, Biopharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 74: UK 7-Year Perspective for Cell Lysis/Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biopharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2020 & 2027
  • Table 75: Rest of Europe Current & Future Analysis for Cell Lysis/Cell Fractionation by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 76: Rest of Europe 7-Year Perspective for Cell Lysis/Cell Fractionation by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2020 & 2027
  • Table 77: Rest of Europe Current & Future Analysis for Cell Lysis/Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 78: Rest of Europe 7-Year Perspective for Cell Lysis/Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2020 & 2027
  • Table 79: Rest of Europe Current & Future Analysis for Cell Lysis/Cell Fractionation by End-Use - Research Laboratories & Institutes, Biopharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 80: Rest of Europe 7-Year Perspective for Cell Lysis/Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biopharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2020 & 2027
  • Table 81: Asia-Pacific Current & Future Analysis for Cell Lysis/Cell Fractionation by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 82: Asia-Pacific 7-Year Perspective for Cell Lysis/Cell Fractionation by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2020 & 2027
  • Table 83: Asia-Pacific Current & Future Analysis for Cell Lysis/Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 84: Asia-Pacific 7-Year Perspective for Cell Lysis/Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2020 & 2027
  • Table 85: Asia-Pacific Current & Future Analysis for Cell Lysis/Cell Fractionation by End-Use - Research Laboratories & Institutes, Biopharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 86: Asia-Pacific 7-Year Perspective for Cell Lysis/Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biopharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2020 & 2027
  • Table 87: Rest of World Current & Future Analysis for Cell Lysis/Cell Fractionation by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 88: Rest of World 7-Year Perspective for Cell Lysis/Cell Fractionation by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2020 & 2027
  • Table 89: Rest of World Current & Future Analysis for Cell Lysis/Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 90: Rest of World 7-Year Perspective for Cell Lysis/Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2020 & 2027
  • Table 91: Rest of World Current & Future Analysis for Cell Lysis/Cell Fractionation by End-Use - Research Laboratories & Institutes, Biopharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 92: Rest of World 7-Year Perspective for Cell Lysis/Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biopharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2020 & 2027

IV. COMPETITION
  • Total Companies Profiled: 44
Note: Product cover images may vary from those shown